0.419
                                            Schlusskurs vom Vortag:
              $0.4472
            Offen:
              $0.444
            24-Stunden-Volumen:
                934.22K
            Relative Volume:
              0.27
            Marktkapitalisierung:
                $17.36M
            Einnahmen:
              $1.50M
            Nettoeinkommen (Verlust:
              $-64.59M
            KGV:
              -0.2509
            EPS:
                -1.67
            Netto-Cashflow:
                $-55.17M
            1W Leistung:
              -14.37%
            1M Leistung:
              -21.46%
            6M Leistung:
                -0.31%
            1J Leistung:
              -88.80%
            Leap Therapeutics Inc Stock (LPTX) Company Profile
Firmenname
                  
                      Leap Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617 252 4343
                    
                Adresse
                  
                      47 THORNDIKE STREET, CAMBRIDGE, MA
                    
                Vergleichen Sie LPTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                LPTX
                            
                             
                        Leap Therapeutics Inc 
                           | 
                    0.419 | 25.33M | 1.50M | -64.59M | -55.17M | -1.67 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-01-29 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2025-01-29 | Herabstufung | Robert W. Baird | Outperform → Neutral | 
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2021-10-04 | Eingeleitet | Mizuho | Buy | 
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform | 
| 2020-06-29 | Eingeleitet | Piper Sandler | Overweight | 
| 2020-02-11 | Eingeleitet | Robert W. Baird | Outperform | 
| 2019-11-15 | Herabstufung | Raymond James | Outperform → Mkt Perform | 
| 2019-09-13 | Fortgesetzt | Raymond James | Outperform | 
| 2017-03-07 | Eingeleitet | Ladenburg Thalmann | Buy | 
                    Alle ansehen
                    
                  
                Leap Therapeutics Inc Aktie (LPTX) Neueste Nachrichten
What RSI levels show for Leap Therapeutics Inc. (5MC) stockWeekly Gains Summary & Safe Capital Allocation Plans - newser.com
Will Leap Therapeutics Inc. (5MC) stock benefit from infrastructure bill2025 Year in Review & Scalable Portfolio Growth Ideas - newser.com
Is Leap Therapeutics Inc. (5MC) stock undervalued historicallyAnalyst Downgrade & Expert Curated Trade Setups - newser.com
Can Leap Therapeutics Inc. stock sustain institutional interestJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
What insider trading reveals about Leap Therapeutics Inc. stockJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
[DEF 14A] LEAP THERAPEUTICS, INC. Definitive Proxy Statement - Stock Titan
Trend analysis for Leap Therapeutics Inc. this weekQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
What valuation ratios show for Leap Therapeutics Inc. (5MC) stockSwing Trade & Daily Stock Momentum Reports - newser.com
Identifying reversal signals in Leap Therapeutics Inc.July 2025 Levels & Risk Controlled Daily Plans - newser.com
What consensus target says about Leap Therapeutics Inc. (5MC) stockJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Tools to assess Leap Therapeutics Inc.’s risk profile2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
Will Leap Therapeutics Inc. (5MC) stock sustain uptrend momentumWeekly Profit Recap & High Win Rate Trade Tips - newser.com
Why hedge funds are buying Leap Therapeutics Inc. stock2025 Geopolitical Influence & Low Risk High Reward Ideas - newser.com
Why Leap Therapeutics Inc. stock is popular among millennialsPortfolio Gains Report & Risk Controlled Daily Plans - newser.com
Can swing trading help recover from Leap Therapeutics Inc. lossesJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
How Leap Therapeutics Inc. (5MC) stock performs during market turbulenceTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
How strong is Leap Therapeutics Inc. stock balance sheetJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Forecasting Leap Therapeutics Inc. price range with options dataInsider Buying & Free Verified High Yield Trade Plans - newser.com
Can Leap Therapeutics Inc. stock continue upward trend2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Will Leap Therapeutics Inc. stock outperform growth indexes2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com
Is Leap Therapeutics Inc. (5MC) stock a defensive play amid uncertaintyInsider Buying & Weekly Stock Performance Updates - newser.com
Will Leap Therapeutics Inc. (5MC) stock remain on Wall Street radar2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-31 05:04:37 - newser.com
Will Leap Therapeutics Inc. price bounce be sustainable2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Will Leap Therapeutics Inc. outperform the marketLong Setup & Expert Approved Momentum Trade Ideas - newser.com
Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):